Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies

Kyle RA, Rajkmar SV. Plasma cell disorders. Cecil textbook of medicine. 22nd ed. 2004. p. 1184–95.

Kyle RA, Theraneau TM, Rajkumar SV, et al. A long term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564–9.

Surveillance, Epidemiology and End Results Programme Public Use Data. Bethesda, MD: National Cancer Institute, Cancer Statistics Branch; 2004.

Ciabarra A, Latov N. Neuropathy associated with monoclonal gammopathy. Neurology. 2001. http://www.medlink.com . Accessed 2001.

Willison HJ. Anti-glycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psych. 1994;57:1303–7.

Kricka LJ, Phil D, Chem C, et al. TIETZ text book of clinical chemistry and molecular diagnostics. Opt Tech. 2006;3:85–8.

Quarles RH. Glycoproteins of the myelin sheath. J Mol Neurosci. 1997;8:1–12.

Kimura J. Electrodiagnosis in disease of nerve and muscle, 3rd ed. Oxford: Oxford University Press; 2001.

Lozeron P, Adams D. Monoclonal gammopathy and neuropathy. Curr Opin Neurol. 2007;20(5):536–41.

Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, et al. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology. 2009;73:688–95.

Gorson K, Ropper A. Axonal neuropathy associated with monoclonal gammopathy of undetermined significance. J Neurol Neurosurg Psychiatry. 1997;63:163–8.

Meucci M, Baldini L, Cappellari A, et al. Antimyelin associated glycoprotein antibodies predict the development of neuropathy in asymptomatic patients with IgM monoclonal gammopathy. Ann Neurol. 1999;46:119–22.

Goldfarb AR, Sander HW, Brannagan TH 3rd, Magda P, Latov N. Characterization of neuropathies associated with elevated IgM serum levels. J Neurol Sci. 2005;228(2):155–60.

Caudie C, Antoine JC, Viol C, et al. A trial of 117 immune mediated peripheral neuropathies associated with monoclonal IgM. Ann Biol Clin. 2006;64:353–9.

Kyle RA. Monoclonal proteins in neuropathy. Neurol Clin. 1992;10:713–34.

Dispernzieri A, Kyle RA. Neurological aspects of multiple myeloma and related disorders. Best Pract Res Clin Haematol. 2005;18:673–88.

Graces-Sanchez M, Dyck PJ, Kyle RA, et al. Anti-MAG in IgM amyloidosis may influence the expression of neuropathy in rare patients. Muscle Nerve. 2008;37:490–5.

Kuijf NL, Eurelings M, Tio-Gillen AP, et al. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology. 2009;73(9):688–95.

Steck AJ, Kuntzer T, Erb S, et al. Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies. J Neurol. 2000;247:467–72.

Nobile-Orazio E, Marmiroli P, Baldini L, et al. Peripheral neuropathy in macroglobulinemia. Incidence and antigen specificity of M proteins. Neurology. 1987;37:1506–15.

Rajkumar SV, Kyle RA, Melton LJ, et al. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clinic survey 2004;79:859–66.

Matà S, Borsini W, Ambrosini S, et al. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity. Eur J Neurol. 2011;18:1067–73.

Sherman WH, Latov N, Lange DJ, et al. Peripheral neuropathy and anti-MAG antibodies. CRC Neurobiol. 1988;4:301–32.

Chassande B, Leger JM, Younes-Chennoufi AB, et al. Peripheral between M protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve. 1997;10:55–62.

Nobile-Orazio E, Alberto C, Alberto P. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve. 2005;31:663–80.

Steven P, Turnbull VJ, Papadobpoulus R, et al. High titer IgM anti-sulfatide in individuals with IgM paraproteinemia and associated peripheral neuropathy. Immunol Cell Biol. 2000;78:124–32.

Wilson JR, Stillsworth JD, Fisher MA. Electrodiagnostic patterns in MGUS neuropathy. Electromyogr Clin Neurophysiol. 2001;41:409–18.

Come G, Roveri I, Swan A, et al. Randomized controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol. 2002;249:1370–7.

Levine T, Pestronk A, Florence J, et al. Peripheral neuropathies in Waldenström’s macroglobulinaemia. J Neurol Neurosurg Psychiatry. 2006;77:224–8.

Baehring JM, Hochberg EP, Raje N, Ulrickson M, Hochberg FH. Neurological manifestations of Waldenström macroglobulinemia. Nat Rev Neurol. 2008;4:547–56.

Kelly JJ. The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve. 1983;6(7):504–9.

Kelly JJ. Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance. Rev Neurol Dis. 2008;5:14–22.

Dimachkie M. Polyneuropathy associated with anti-MAG IgM antibodies. Neurology. 1998. http://www.medlink.com (Medlink: Originally released July 13, 1998; last updated November 10, 2010; expires November 10, 2013).